Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 373

1.

Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug.

AFFIRM First Antiarrhythmic Drug Substudy Investigators.

J Am Coll Cardiol. 2003 Jul 2;42(1):20-9.

2.

[Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].

Niu F, Huang CX, Jiang H, Yang B, Guo WL, Chen YX, Jin CR, Liu ZM.

Zhonghua Yi Xue Za Zhi. 2006 Jan 10;86(2):121-3. Chinese.

PMID:
16620720
4.

A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.

Vijayalakshmi K, Whittaker VJ, Sutton A, Campbell P, Wright RA, Hall JA, Harcombe AA, Linker NJ, Stewart MJ, Davies A, de Belder MA.

Am Heart J. 2006 Apr;151(4):863.e1-6.

PMID:
16569550
5.

Atrial fibrillation: rate control often better than rhythm control.

[No authors listed]

Prescrire Int. 2004 Apr;13(70):64-9.

PMID:
15148984
6.

[Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].

Márk L, Erdej F, Dani G, Borbély M, Sziklai G, Nagy E, Hajdara I, Katona A.

Orv Hetil. 2004 May 9;145(19):1001-6. Hungarian.

PMID:
15181735
7.

Intravenous amiodarone for cardioversion of recent-onset atrial fibrillation.

Cybulski J, Kułakowski P, Budaj A, Danielewicz H, Maciejewicz J, Kawka-Urbanek T, Ceremuzyński L.

Clin Cardiol. 2003 Jul;26(7):329-35.

8.

Arrhythmias in the intensive care patient.

Trappe HJ, Brandts B, Weismueller P.

Curr Opin Crit Care. 2003 Oct;9(5):345-55. Review.

PMID:
14508146
10.

Amiodarone versus sotalol for atrial fibrillation.

Singh BN, Singh SN, Reda DJ, Tang XC, Lopez B, Harris CL, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis HD Jr, Raisch DW, Ezekowitz MD; Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators.

N Engl J Med. 2005 May 5;352(18):1861-72.

11.

Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.

Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagné P, Nattel S, Thibault B.

N Engl J Med. 2000 Mar 30;342(13):913-20.

12.

A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.

Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, Paglino G, Mazzone P, Sora N, Greiss I, Santagostino A, LiVolsi L, Pappone N, Radinovic A, Manguso F, Santinelli V.

J Am Coll Cardiol. 2006 Dec 5;48(11):2340-7. Epub 2006 Oct 16.

13.

The frequency analysis of signal-averaged ECG of P wave as predictor of efficacy of class III antiarrhythmic drugs to maintain sinus rhythm in recurrent idiopathic atrial fibrillation.

Barbosa EC, Barbosa PR, Ginefra P, de Souza Bomfim A, Boghossian SH, da Rocha PJ, Filho FM.

Ann Noninvasive Electrocardiol. 2001 Jan;6(1):43-9.

PMID:
11174862
14.

Risks and benefits of rate control versus maintenance of sinus rhythm.

Saxonhouse SJ, Curtis AB.

Am J Cardiol. 2003 Mar 20;91(6A):27D-32D. Review.

PMID:
12670639
15.

Low-dose amiodarone versus sotalol for suppression of recurrent symptomatic atrial fibrillation.

Kochiadakis GE, Igoumenidis NE, Marketou ME, Solomou MC, Kanoupakis EM, Vardas PE.

Am J Cardiol. 1998 Apr 15;81(8):995-8.

PMID:
9576159
16.

Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.

Chung MK, Shemanski L, Sherman DG, Greene HL, Hogan DB, Kellen JC, Kim SG, Martin LW, Rosenberg Y, Wyse DG; AFFIRM Investigators.

J Am Coll Cardiol. 2005 Nov 15;46(10):1891-9. Epub 2005 Oct 21.

17.

A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.

Gulizia M, Mangiameli S, Orazi S, Chiarandà G, Piccione G, Di Giovanni N, Colletti A, Pensabene O, Lisi F, Vasquez L, Grammatico A, Boriani G; PITAGORA Study Investigators.

Am Heart J. 2008 Jan;155(1):100-7, 107.e1. Epub 2007 Nov 26.

PMID:
18082498
18.

Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial.

Mooss AN, Wurdeman RL, Sugimoto JT, Packard KA, Hilleman DE, Lenz TL, Rovang KS, Arcidi JM, Mohiuddin SM.

Am Heart J. 2004 Oct;148(4):641-8.

PMID:
15459595
19.
20.

Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T]).

Singh SN, Singh BN, Reda DJ, Fye CL, Ezekowitz MD, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis HD Jr, Antman EM, Falk RH, Lopez B, Tang XC.

Am J Cardiol. 2003 Aug 15;92(4):468-72.

PMID:
12914883

Supplemental Content

Support Center